MedTrace Logo

A Proof of Concept Top Evaluate a Novel Penile Lengthening Protocol

NCT04231422 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-01-18

No results posted yet for this study

Summary

The objective of this study is to examine and quantify the efficacy and safety of a new treatment protocol using platelet-rich plasma for penile length enhancement.

Conditions

  • Penile Elongation

Interventions

COMBINATION_PRODUCT

Platelet-rich plasma

12mL of platelet-rich plasma injected into cavernosal bodies bilaterally

Sponsors & Collaborators

  • Judson Brandeis

    lead INDUSTRY

Principal Investigators

  • Judson Brandeis, MD · BrandeisMD

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-12
Primary Completion
2021-05-12
Completion
2021-07-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04231422 on ClinicalTrials.gov